These results indicate that anti‐CTLA4 antibody binds to the tumour cell‐intrinsic CTLA4 on the cell surface, resulting in activation of the EGFR pathway, which induces PD‐L1 expression. The gene discussed is EGFR; the disease is neoplasm.